A detailed history of Raymond James & Associates transactions in Schrodinger, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 14,202 shares of SDGR stock, worth $351,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,202
Previous 18,829 24.57%
Holding current value
$351,073
Previous $364,000 27.75%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$18.05 - $24.02 $83,517 - $111,140
-4,627 Reduced 24.57%
14,202 $263,000
Q2 2024

Jul 19, 2024

SELL
$18.65 - $28.5 $29,802 - $45,543
-1,598 Reduced 7.82%
18,829 $364,000
Q1 2024

Apr 22, 2024

BUY
$24.74 - $35.13 $51,706 - $73,421
2,090 Added 11.4%
20,427 $551,000
Q4 2023

Jan 16, 2024

BUY
$21.62 - $37.21 $141,654 - $243,799
6,552 Added 55.6%
18,337 $656,000
Q3 2023

Oct 24, 2023

BUY
$27.34 - $55.37 $322,201 - $652,535
11,785 New
11,785 $333,000
Q2 2022

Aug 12, 2022

SELL
$21.39 - $35.9 $160,681 - $269,680
-7,512 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$24.84 - $36.12 $70,073 - $101,894
-2,821 Reduced 27.3%
7,512 $256,000
Q4 2021

Feb 08, 2022

SELL
$33.38 - $59.25 $833,498 - $1.48 Million
-24,970 Reduced 70.73%
10,333 $360,000
Q3 2021

Nov 02, 2021

BUY
$53.75 - $76.55 $11,932 - $16,994
222 Added 0.63%
35,303 $1.93 Million
Q2 2021

Aug 11, 2021

SELL
$59.02 - $78.8 $465,667 - $621,732
-7,890 Reduced 18.36%
35,081 $2.65 Million
Q1 2021

May 14, 2021

SELL
$64.61 - $113.09 $321,047 - $561,944
-4,969 Reduced 10.37%
42,971 $3.28 Million
Q4 2020

Feb 12, 2021

SELL
$48.06 - $84.4 $882,814 - $1.55 Million
-18,369 Reduced 27.7%
47,940 $3.8 Million
Q3 2020

Nov 04, 2020

BUY
$46.87 - $93.33 $9,186 - $18,292
196 Added 0.3%
66,309 $3.15 Million
Q2 2020

Jul 28, 2020

BUY
$36.12 - $91.57 $2.04 Million - $5.17 Million
56,487 Added 586.82%
66,113 $6.05 Million
Q1 2020

Apr 21, 2020

BUY
$26.6 - $52.99 $256,051 - $510,081
9,626 New
9,626 $415,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.53B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.